NeuroPace (NPCE) Other Operating Expenses (2024 - 2026)

NeuroPace has reported Other Operating Expenses for 3 years, with the latest figure at $6.9 million in Q2 2026.

• On a quarterly basis, Other Operating Expenses rose 0.77% year-over-year to $6.9 million in Q2 2026; TTM through Jun 2026 was $27.7 million, a 6.14% increase from a year earlier, with the FY2025 full-year figure at $27.9 million, up 17.9% from the prior year.
• Other Operating Expenses was $6.9 million for Q2 2026 at NeuroPace, down from $7.2 million in the prior quarter.
• The five-year high for Other Operating Expenses was $7.4 million in Q1 2025, with the low at $5.8 million in Q3 2024.
• Average Other Operating Expenses over 3 years is $6.6 million, with a median of $6.8 million recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Other Operating Expenses gained 16.15% in 2025, then retreated 3.37% in 2026.
• Over 3 years, Other Operating Expenses stood at $6.0 million in 2024, then advanced by 16.15% to $7.0 million in 2025, then dropped by 1.84% to $6.9 million in 2026.
• The last three Other Operating Expenses figures came in at $6.9 million (Q2 2026), $7.2 million (Q1 2026), and $7.0 million (Q4 2025), per Business Quant data.